| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.98▼ | 1.01▼ | 0.99▼ | 0.88▲ | 0.93▲ |
| MA10 | 1.00▼ | 0.97▼ | 0.93▲ | 0.85▲ | 0.84▲ |
| MA20 | 0.98▼ | 0.91▲ | 0.89▲ | 0.89▲ | 0.84▲ |
| MA50 | 0.90▲ | 0.86▲ | 0.85▲ | 0.82▲ | 1.23▼ |
| MA100 | 0.86▲ | 0.88▲ | 0.90▲ | 0.82▲ | 2.18▼ |
| MA200 | 0.89▲ | 0.85▲ | 0.82▲ | 1.13▼ | 4.70▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | 0.010▲ | 0.016▲ | 0.001▲ | 0.054▲ |
| RSI | 51.905▲ | 60.297▲ | 61.682▲ | 62.099▲ | 49.702▼ |
| STOCH | 13.244▼ | 79.052 | 82.538▲ | 41.166 | 64.368 |
| WILL %R | -100.000▼ | -35.979 | -35.979 | -29.762 | -24.601▲ |
| CCI | -118.713▼ | 40.930 | 73.319 | 130.949▲ | 100.098▲ |
|
Tuesday, April 21, 2026 03:15 AM
DOYLESTOWN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 0.93 | 1.06 | 0.9027 | 0.9799 | 974,497 |
| 07/05/26 | 0.899 | 0.9483 | 0.867 | 0.8807 | 313,613 |
| 06/05/26 | 0.83 | 0.8755 | 0.8014 | 0.8335 | 181,457 |
| 05/05/26 | 0.8656 | 0.8656 | 0.8158 | 0.8432 | 188,681 |
| 04/05/26 | 0.811 | 0.8527 | 0.811 | 0.8408 | 40,374 |
| 01/05/26 | 0.7901 | 0.818 | 0.7901 | 0.818 | 45,375 |
| 30/04/26 | 0.81 | 0.81 | 0.7915 | 0.7999 | 100,471 |
| 29/04/26 | 0.83 | 0.8348 | 0.7701 | 0.819 | 226,821 |
| 28/04/26 | 0.8525 | 0.8608 | 0.8067 | 0.8369 | 93,038 |
| 27/04/26 | 0.952 | 0.952 | 0.8527 | 0.8611 | 154,912 |
|
|
||||
|
|
||||
|
|